| Source: |
| Type: |
| TrxR1 or TXNRD1 (Thioredoxin Reductase 1) Redox Control, Stress Tolerance, and Therapy Resistance • Many studies have found that an elevated expression of TrxR1 in breast tumors, NSCLC, HCC correlates with increased tumor aggressiveness and a poorer prognosis. -TrxR1 expression was elevated by >50 fold in FaDu and HeLa cells, and by >20 fold in SCC-1 compared to either MSK-Leuk1 or keratinocytes.
High TXNRD1 expression often associates with:
-Advanced stage
-Therapy resistance
-Reduced survival
TrxR1 Inhibition
-Collapses redox control
-Causes rapid ROS accumulation
-Triggers apoptosis, especially in high-stress tumors
|
| 5862- | carbop, | Cisplatin, | Molecular Mechanisms of Resistance and Toxicity Associated with Platinating Agents |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1207 State#:% Dir#:3
wNotes=0 sortOrder:rid,rpid